Thomas Fuchß

Drug Discovery & Development, innovation, #science, #oncology, #MedChem, #ADC, #conjugates, @GDCh_aktuell, #mentoring-Join my network, views/opinions are my own

[Ingo Hartung @HartungIngo]

The most recent report from our exceptionally productive collaboration with @g_laudadio & @KappeLab is now online @ChemRxiv: How to optimize the many variables of electrochemistry in flow? With case studies of high relevance for medicinal chemistry. https://t.co/xOKGnY31Ys

[Thomas Fuchß @Fuchss_Thomas]

Wrapping up an inspiring #AACR2025 in Chicago! A huge thank you to all the researchers, clinicians, and advocates who shared their groundbreaking work and insights. Together, we're advancing cancer research and pushing boundaries! #CancerResearch #MerckKGaA #Innovation

[Thomas Fuchß @Fuchss_Thomas]

Excited to have been an invited speaker at the @RSC_BMCS’s #ConformationalDesign25 symposium yesterday in #Cambridge, hosted by AstraZeneca! I had the opportunity to discuss ATM Kinase Inhibitor Lartesertib and its pioneering application of atropisomerism in drug design. #MedChem

[Thomas Fuchß @Fuchss_Thomas]

Don't miss the chance to showcase your work at #EFMCASMC2025! Register now and submit your abstracts for oral or poster presentations. Join us in advancing #MedChem #MedicinalChemistry
👉 https://t.co/ulpZg87NTp
@EuroMedChem @organic_portal @YoungSciNet #DrugDesign #DrugDiscovery

[Thomas Fuchß @Fuchss_Thomas]

Just wrapped up a Hanson Wade event in Boston! Focused on exploring novel strategies & next generation assets incl brain-penetrant, selecting optimal combinations, utilizing biomarkers & identifying novel targets to overcome inhibitor resistance in #CancerResearch #DrugDiscovery.

[Thomas Fuchß @Fuchss_Thomas]

Goodbye, India! After 4 amazing days filled with vibrant culture, enriching encounters, delicious food, and warm hospitality it's time to leave. Thank you for the memories! #IncredibleIndia #TravelDiaries #GoodbyeIndia

[Thomas Fuchß @Fuchss_Thomas]

Indeed, 40 years of ADCs! With novel FDA-approved therapies & numerous in trials, R&D is reshaping cancer treatment. Focus remains on enhancing efficacy & understanding toxicity to maximize patient outcomes. #MedicinalChemsitry #CancerResearch #ADCs

[Ingo Hartung @HartungIngo]

A must read: The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development | Cancer Discovery | American Association for Cancer Research https://t.co/DrjUckHiQV

[Thomas Fuchß @Fuchss_Thomas]

Had a great time leading a roundtable at Proventa's Medicinal Chemistry Strategy Meeting Europe 2024 in London! We discussed leveraging Deep Learning & Generative AI for molecule design, drug discovery & optimization in chemistry #MedicinalChemistry #AI #DrugDiscovery
#ProventaSM

[Thomas Fuchß @Fuchss_Thomas]

The 6th MiTraC at #UniMedizinMainz sparked engaging discussions on targeting #Cancer via synthetic lethality interdependencies. Highlights included updates on PARP1 MoA, innovative CRISPR/Cas9 screens & ML applications in DNA damage response.
#CancerResearch #Oncology @merckgroup

[Thomas Fuchß @Fuchss_Thomas]

As a former speaker & medicinal chemist, I’m proud to have participated in the #EFMCISMC2024 Symposium! The caliber of research & collaboration was outstanding. Grateful for the insightful discussions & re-newed connections made. Excited for the future of our field! @EuroMedChem

[Thomas Fuchß @Fuchss_Thomas]

Congratulations to the winner of the 2024 Merck Innovation Cup - Team Medicinal Chemistry!

[Merck @merckgroup]

Our Innovation Cup brought together students & young professionals worldwide to learn from experts & work on innovative projects. Congrats to this year's winners for their outstanding project! #InnovationCup

[Thomas Fuchß @Fuchss_Thomas]

An exhilarating day at the #Curious2024 @FutureInsight conference, exploring frontiers of innovation in science and technology, filled with stimulating discussions and networking with dynamic peers. #unitedbyscience @merckgroup

[Ulrich Betz @UlrichBetz]

The new 2024 Merck Research Grants are live - get funding for pioneering novel approaches for the screening & discovery of molecular glues!
Apply today at:
https://t.co/s1gJO98j1T
#merckresearchgrants #curiousopportunityboard

[Thomas Fuchß @Fuchss_Thomas]

Join us as a Director #MedicinalChemistry & project leader @MerckHealthcare Darmstadt, near Frankfurt. If you're a PhD holder in synthetic chemistry with 10+ years of industry experience, apply now.🔗 [Job ID: 273877] https://t.co/qV284cVCN2 #ScienceJobs #Innovation

[Thomas Fuchß @Fuchss_Thomas]

🌟 We're hiring! Join us as Associate Director Medicinal Chemistry @MerckHealthcare, Darmstadt, Germany. Contribute to oncology & immunology research, lead international project teams. Apply now, be part of our diverse team! #JobOpening #ScienceCareers https://t.co/2BV41mMhQF

[Thomas Fuchß @Fuchss_Thomas]

Now is your chance to participate in this unique hybrid event that will take place again on July 12-14, 2022 on-site in Darmstadt, Germany and online. https://t.co/cORVO6A0FJ

[Keith Hornberger @KRHornberger]

Thankfully the CICR came through at the end of the session with a summary slide and no posting restrictions! #AACR24

[Ulrich Betz @UlrichBetz]

Easter egg - 100 FREE student tickets for the Curious2024 - Future Insight Conference in Mainz in July 2024 sponsored by vfa - Verband der forschenden Pharmaunternehmen. Pick your free ticket up at https://t.co/NTUBKHWk0X add "vfa ticket" to your affiliation #curiousfutureinsight

[Ingo Hartung @HartungIngo]

Congrats to Oliver Schadt, Dieter Dorsch & Frank Stieber @merckgroup for winning the Friedrich Stolz Award of the section for medicinal chemistry of the @GDCh_aktuell. Helping patients in need starts with designing & synthesizing the right molecule. What they did!

[Thomas Fuchß @Fuchss_Thomas]

Exciting opportunity alert! Join our team at Merck KGaA, Darmstadt, Germany as a Postdoc in Synthesis Automation within our Medicinal Chemistry and Drug Design Department. If you're passionate about advancing drug discovery through automation, apply now! https://t.co/VkEm6a3jp7